[Simultaneous radiochemotherapy and endoluminal HDR brachytherapy in esophageal cancer].

Purpose: To study efficacy and toxicity of radiochemotherapy in esophageal cancer including initial endoluminal high-dose-rate brachytherapy (HDR-BT).

Patients And Methods: Between 01/1995 and 06/2005, 61 patients with esophageal cancer were treated preoperatively with definitive and palliative intent. Treatment started with intraluminal HDR-BT for recanalization of the esophagus (single fraction size of 8 Gy in 0.

[Radio-chemotherapy for non-resectable primary esophageal malignant melanoma].

Aim: to demonstrate the simultaneous radio-chemotherapy of primary esophageal malignant melanoma on the basis of one case.

Patient And Methods: 68-years-old male patient with malignant melanoma in middle part of the esophagus. The therapy was started with intraluminal high-dose-rate afterloading brachytherapy for the recanalisation of the esophagus (8 Gy in 0.

[The radiochemotherapy of the oesophageal cancer].

Aim: To prove the efficacy of the simultaneous radio-chemotherapy of the inoperable or non-resectable esophageal cancer.

Methods: Twenty-nine patients with inoperable or non-resectable oesophageal cancer were treated between January 1995 and December 2002. The therapy was started with intraluminal HDR AL irradiation for the recanalisation of the esophagus (8 Gy at 0.